Academy Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
Academy Capital Management's NVO Position: Q1 2026 in Review
Academy Capital Management increased its Novo Nordisk (NVO) stake by 97% in Q1 2026, buying an estimated $16.7M and bringing the position to 719,230 shares worth $26.4M. The position accounts for 3.78% of the portfolio, ranked #12.
Academy Capital Management first reported a position in NVO in Q4 2024 and has held it in 6 quarters since. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Academy Capital Management held 719,230 shares of Novo Nordisk worth $26.4M as of Q1 2026.
- Academy Capital Management bought 353,447 Novo Nordisk shares in Q1 2026, an estimated $16.7M.
- Novo Nordisk made up 3.78% of Academy Capital Management's portfolio in Q1 2026, its #12 holding.
- Academy Capital Management first reported a position in Novo Nordisk in Q4 2024 and has held it in 6 quarters since.
- 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Academy Capital Management's 13F filing for Q1 2026, filed 14 May 2026.